From the NetDoc medical news feed

Oct. 29, 2006 – The Centers for Disease Control and Prevention (CDC) recently released new guidelines to prevent increases of drug-resistant infections in healthcare settings.

The new guidelines aim to stop increasing rates of drug-resistant infections by instituting comprehensive infection control programs and undertaking aggressive strategies to reduces rates of drug resistance.

During the past 30 years the number of antibiotic-resistant bacterial infections has significantly increased. Antibiotic resistance in staphylococcus aureus bacterial infections has risen from 2% in 1972 to 63% in 2004. In fact, methicillin-resistant infection, MRSA, is the fastest growing problem in hospitals and other healthcare facilities.

Dr. Denise Cardo, director of CDC's Division of Healthcare Quality Promotion, indicates that peventing drug resistant infections requires a concerted effort of healthcare facilities to prevent complications
resulting in less effective patient care.

The new guidance report, Management of Multidrug-Resistant Organisms in Healthcare Settings, was developed by infection control experts working with CDC's Healthcare Infection Control Practices Advisory Committee (HICPAC).

Staph infections in healthcare settings occur most frequently among persons with poor immune systems. Complications include bloodstream infections, surgical site infections or pneumonia.

Some of the new CDC guidelines include: ensuring that prevention programs are adequately staffed, tracking infection rates, staff using standard infection control practices and, following accepted guidelines for antibiotics use. If the suggested guidelines don't improve rates,
healthcare facilities must screen patients who may be at high risk of carrying drug-resistant strains.
 
Sources:

http://www.cdc.gov/od/oc/media/pressrel/r061019.htm

http://www.cdc.gov/ncidod/dhqp/

 

About the Author
 
Jeanne Bohm, Ph.D. is a cancer biologist by training, a medical writer and an experienced science educator.

The author has no financial relationship to any of the companies listed in the article.

 

Topics #CDC #MRSA #MRSA guidelines